Ras signaling pathway in the chemopreventive action of different ratios of fish oil and corn oil in experimentally induced colon carcinogenesis

Nutrition and Cancer

Volumn 64, Issue 4, 2012, Pages 559-568

  Kansal, S ^a   Negi, A K ^a   Bhatnagar, A ^a   Agnihotri, N ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CORN OIL; ETHYLENEDIAMINE; FISH OIL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN C FOS; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CHEMOPROPHYLAXIS; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; COLON; COLONIC NEOPLASMS; CORN OIL; DIMETHYLHYDRAZINES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FISH OILS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; RAS PROTEINS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

ANIMALIA; RATTUS NORVEGICUS; TETRA; ZEA MAYS;

EID: 84861442953     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.675619     Document Type: Article

References (43)

1. Jemal A, Siegel R, Xu J, andWard E: Cancer statistics, 2010. CA Cancer J Clin 60, 277-300, 2010.
2. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56, 365-379, 2002. (Pubitemid 35232740)
3. Cross AJ and Sinha R: Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen 44, 44-55, 2004. (Pubitemid 38982072)
4. Martinez ME: Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Cancer Res 166, 177-211, 2005.
5. Simopoulos AP: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp BiolMed (Maywood) 233, 674-688, 2008.
6. Crawford MA, Gale MM, and Woodford MH: Linoleic acid and linolenic acid elongation products in muscle tissue of Syncerus caffer and other ruminant species. Biochem J 115, 25-27, 1969.
7. Simopoulos AP: Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins, Leukotr Essent Fatty Acids 60, 421-429, 1999. (Pubitemid 29401803)
8. Simopoulos AP: Omega-3 fatty acids and cancer. Indoor Built Environ 12, 405-412, 2003. (Pubitemid 38009688)
9. Sarotra P, Sharma G, Kansal S, Negi AK, Aggarwal R, et al.: Chemopreventive effect of different ratios of fish oil and corn oil in experimental colon carcinogenesis. Lipids 45, 785-798, 2010.
10. Sarotra P, Kansal S, Sandhir R, and Agnihotri N: Chemopreventive effect of different ratios of fish oil and corn oil on prognostic markers, DNA damage and cell cycle in colon carcinogenesis. Eur J Cancer Prev 21, 147-154, 2012.
11. Lowy DR and Willumsen BM: Function and regulation of ras. Annu Rev Biochem 62, 851-891, 1993. (Pubitemid 23237890)
12. WhiteMA,Nicollete C, MindenA, Polverino A,VanAeistL, et al.:Multiple ras functions can contribute to mammalian cell transformation. Cell 80, 541-553, 1995.
13. Shirasawa S, Furuse M,Yokoyama N, and Sasazuki T: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260, 85-88, 1993. (Pubitemid 23122749)
14. Worthley DL: Colorectal carcinogenesis: road maps to cancer. World J Gastroenterol 13, 3784-3791, 2007. (Pubitemid 47272303)
15. Roskoski R: Protein prenylation: a pivotal posttranslational process. Biochem Biophys Res Commun 303, 1-7, 2003.
16. Turatti E, da Costa NA, de Magalhaes MH, de Sousa SO: Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions. J Oral Sci 47, 71-76, 2005.
17. Pruitt K and Der CJ: Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 171, 1-10, 2001. (Pubitemid 32727350)
18. Singh J, Hamid R, and Reddy BS: Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis 19, 985-989, 1998. (Pubitemid 28375392)
19. Collett ED, Laurie AD, Yang-Yi F, Lupton JR, and Chapkin RS: n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenicRas activation in colonocytes. Am J Physiol Cell Physiol 280, 1066-1075, 2001.
20. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, et al.: The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene 23, 8571-8580, 2004. (Pubitemid 39576463)
21. Committee on Laboratory Animal Diets: Control of diets in laboratory animal experimentation. National Academy of Sciences Washington DC, 1978.
22. Latham P, Lund EK, and Johnson IT: Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 20, 645-650, 1999. (Pubitemid 29151302)
23. Kaneko T, Tahara S, and Takabayashi F: Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2-dimethylhydrazine in rat colons. Biol Pharm Bull 30, 2052-2057, 2007. (Pubitemid 350097038)
24. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, et al.: An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocytes apoptosis. J Nutr 134, 3233-3238, 2004. (Pubitemid 39602991)
25. Xiong HQ: Molecular targeting therapy for pancreatic cancer. Cancer Chemother Pharmacol 54, S69-S77, 2004. (Pubitemid 39517752)
26. Lampe E, Heinrich M, Walczak H, and Kalthoff H: CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene 20, 4258-4269, 2001. (Pubitemid 32762200)
27. Saxena N, Lahiri SS, Hambarde S, and Tripathi RP: Ras: target for cancer therapy. Cancer Invest 9, 948-955, 2008.
28. Zhou Q, Snider NT, Liao J, Li DH, Anita H, et al.: Characterization of in vivo keratin 19 phosphorylation on tyrosine-391. PLoS One 5, e13538, 2010.
29. Ardito G, Luca R, Alma B, Alessandro S, Francesca M, et al.: Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study. J Exper Clin Cancer Res 29, 77, 2010.
30. El DD, Nasr AL, and Alowami S: Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. Diag Pathol 3, 5, 2008.
31. El DD, Nasr AL, Babay S, and Alowami S: Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid. Pathol Res Practice 205, 303-309, 2009.
32. Bartolazzi A, Orlandi F, Saggiorato E,Volante M, Arecco F, et al.:Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 9, 543-549, 2008.
33. Stammberger P and Baczako K: Cytokeratin 19 expression in human gastrointestinal mucosa during human prenatal development and in gastrointestinal tumours: relation to cell proliferation. Cell Tissue Res 298, 377-381, 1999. (Pubitemid 29512090)
34. Malumbres M and Pellicer A: Ras pathways to cell cycle control and cell transformation. Front Biosci 3, 887-912, 1998.
35. Zoumpourlis V, Solakidi S, Papathoma A, and Papaevangeliou D: Alterations in signal transduction pathways implicated in tumor progression during multistage mouse skin carcinogenesis. Carcinogenesis 24, 1159-1165, 2003. (Pubitemid 36927055)
36. Singh J, Rachid H, and Reddy BS: Dietary fat and colon cancer:modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 57, 253-258, 1997. (Pubitemid 27036602)
37. Davidson LA, Joanne RL, Yi-Hai J, and Robert SC: Carcinogen and dietary lipid regulate ras expression and localization in rat colon without affecting farnesylation kinetics. Carcinogenesis 20, 785-791, 1999. (Pubitemid 29191859)
38. Reynoso-Camacho R, Gonzalez-Jasso E, Ferriz-Martinez R, Villalon-Corona B, Loarca-Pina GF, et al.:Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and ?-catenin proteins. Nutr Cancer 63, 39-45, 2011.
39. Park SS, Park SK, Lim JH, Choi YH, Kim WJ, et al.: Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells. Oncol Rep 25, 223-230, 2011.
40. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, et al.: Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17, 590-603, 2003. (Pubitemid 36395654)
41. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, et al.: PI3K/Akt signaling pathway and cancer. Cancer Treat Rev 30, 193-204, 2004.
42. Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, et al.: Akt as a mediator of cell death. Proc Natl Acad Sci USA 100, 11712-11717, 2003. (Pubitemid 37206000)
43. Testa J R and Bellacosa A: AKT plays a central role in tumorogenesis. Proc Natl Acad Sci USA 98, 10983-10985, 2001. (Pubitemid 32928669)